
Malaria Vaccine is Finally Approved for Widespread Rollout
Scientists have been working on an effective malaria vaccine for over 30 years and this month the latest iteration, the RTS, S vaccine made by GlaxoSmithKline and largely funded by the Bill and Melinda Gates Foundation, was approved by the World Health Organization. ( W.H.O.)
Two years ago, clinical trials for the RTS,S vaccine rolled out in Malawi, Kenya and Ghana reaching 800,000 children under five with 2.3 million administered doses. Boasting a strong safety profile according to the W.H.O., the four-dose vaccine that fights against the Plasmodium falciparum parasite from female mosquitoes is advised to begin at five months of age. Scientists and health workers who worked on the clinical trials say the vaccine reduced hospital admission by 30% and “nearly halves the risk of severe malaria over a period of 18 months” according to clinical trial data.
Continue reading “Malaria Vaccine is Finally Approved for Widespread Rollout”